Author name: DrugChatter

Chatbots now answer drug questions that once required a detail rep, a pharmacist, or a Medical Information call center. The […]

On September 30, 2004, Merck pulled Vioxx from every pharmacy shelf in the world. The withdrawal took less than 24

If you want to understand drug shortages, don’t start with FDA dashboards. Start with patient questions. They don’t say “supply

A look at the $50B opportunity reshaping how pharma companies launch, monitor, and defend their brands in the age of

Physicians are increasingly asking AI chatbots how to dose drugs, manage contraindications, and choose between therapies. The AI answers. The

How pharmaceutical brands are losing control of patient conversations, clinical narratives, and competitive positioning inside the black box of generative

Drug companies spend billions crafting brand narratives. AI is rewriting them in real time — and most manufacturers have no

How artificial intelligence is tracking, shaping, and sometimes undermining pharmaceutical brand strategy — and what drug companies need to do

A scan of hundreds of real-world questions on DrugChatter reveals a consistent pattern: patients are not just asking what a

There used to be a reliable playbook. You identified the twenty physicians who shaped prescribing behavior in a given therapeutic

A growing share of medication questions aren’t being asked in exam rooms. They’re being typed into search bars and forums

Patients are increasingly turning to online forums before their first dose—less for diagnosis, more for reassurance. The result is a